Elevated ABCC1 levels in HCC are associated with an unfavorable prognosis, suggesting that ABCC1 is a potential indicator of treatment response and a viable target for enhancing therapeutic outcomes [75]. Here, ABCC1 is linked to hepatocellular carcinoma.